INDSWFTLTDPharmaceuticals & Biotechnology
Ind Swift — Quarterly Results & Earnings
₹15.76
+0.00%
Profit Growth YoY-131.15%Latest quarter
Sales Growth YoY7.15%Latest quarter
Sales CAGR 5Y9.35%5 year compound
Profit CAGR 5Y18.19%5 year compound
📋
Quarterly Performance
YoY Profit Growth-131.15%
🔴 Significant decline
YoY Sales Growth+7.15%
📈 Moderate growth
OPM 5Y Average
9.43%Operating profit margin
EPS Growth 5Y
18.19%Interest Coverage
1.20Higher = safer debt servicing
ROE
N/AROCE
11.86%💡
Growth Analysis
Ind Swift reported YoY profit growth of -131.15% and revenue growth of 7.15% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 9.35% and profits at 18.19% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Ind Swift
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.